Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF
Clinical trial NCT06331624 · COMPLETED
Trial details
- NCT number
- NCT06331624
- Sponsor
- GRI Bio Operations, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-24
- Primary completion
- 2025-09-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.